期刊文献+

辛芩颗粒联合盐酸氮卓斯汀治疗变应性鼻炎的临床研究 被引量:9

Clinical study on Xinqin Granules combined with azelastine hydrochloride in treatment of allergic rhinitis
原文传递
导出
摘要 目的探讨辛芩颗粒联合盐酸氮卓斯汀治疗变应性鼻炎的临床疗效。方法选取2015年1月—2016年1月在商洛市中心医院接受治疗的变应性鼻炎患者176例为研究对象,随机分为对照组和治疗组,每组各88例。对照组鼻喷盐酸氮卓斯汀鼻喷剂,1喷/鼻孔,2次/d。治疗组在对照组基础上口服辛芩颗粒,5 g/次,3次/d。两组均连续用药28 d。观察两组的临床疗效,比较两组的症状评分、RQLQ评分和血清学指标。结果治疗后,对照组和治疗组的总有效率分别为85.23%、94.32%,两组比较差异有统计学意义(P<0.05)。治疗后,两组鼻塞、鼻痒、喷嚏和流涕评分及总评分均显著降低,同组治疗前后比较差异有统计学意义(P<0.05);且治疗组这些观察指标的下降程度明显优于对照组,两组比较差异具有统计学意义(P<0.05)。治疗后,两组日常活动、睡眠、非鼻–结膜炎症、相关行为、鼻部症状、眼部症状和情感反应评分均显著下降,同组治疗前后比较差异有统计学意义(P<0.05);且治疗组这些观察指标的下降程度明显优于对照组,两组比较差异具有统计学意义(P<0.05)。治疗后,两组白细胞介素-4(IL-4)、白细胞介素-5(IL-5)、转化生长因子-α(TGF-α)和免疫球蛋白E(Ig E)均明显升高,而白细胞介素-12(IL-12)和γ-干扰素(IFN-γ)均明显降低,同组治疗前后比较差异有统计学意义(P<0.05);且治疗组这些观察指标的改善程度明显优于对照组,两组比较差异具有统计学意义(P<0.05)。结论辛芩颗粒联合盐酸氮卓斯汀治疗变应性鼻炎具有较好的临床疗效,改善患者临床症状和生活质量,提高机体免疫力,具有一定的临床推广应用价值。 Objective To explore the clinical effect of Xinqin Granules combined with azelastine hydrochloride in treatment of allergic rhinitis. Methods Patients(176 cases) with allergic rhinitis in Shangluo Central Hospital from January 2015 to January 2016 were randomly divided into control and treatment groups, and each group had 88 cases. Patients in the control group were nasal spray administered with Azelastine Hydrochloride Nasal Spray, 1 spray/nostrils, twice daily. Patients in the treatment group were po administered with Xinqin Granules on the basis of the control group, 5 g/time, three times daily. Patients in two groups were treated for 28 d. After treatment, the clinical efficacies were evaluated, and symptom scores, RQLQ scores, and serological indexes in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 85.23% and 94.32%, respectively, and there was difference between two groups(P〈0.05). After treatment, the scores of nasal congestion, nasal itching, sneezing, and runny nose and the total scores in two groups were significantly decreased, and the difference was statistically significant in the same group(P〈0.05). And the observational indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups(P〈0.05). After treatment, the scores of daily activity, sleep, non-nasal conjunctivitis, related behavior, nasal symptoms, eye symptoms, and emotional reaction in two groups were significantly decreased, and the difference was statistically significant in the same group(P〈0.05). And the observational indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups(P〈0.05). After treatment, IL-4, IL-5, TGF-α, and Ig E in two groups were significantly increased, but IL-12 and IFN-γ were significantly decreased, and the difference was statistically significant in the same group(P〈0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups(P〈0.05). Conclusion Xinqin Granules combined with azelastine hydrochloride has clinical curative effect in treatment of allergic rhinitis, and can improve clinical symptoms and quality of life, increase body immunity, which has a certain clinical application value.
作者 张建鹏
出处 《现代药物与临床》 CAS 2016年第11期1808-1812,共5页 Drugs & Clinic
关键词 辛芩颗粒 盐酸氮卓斯汀鼻喷剂 变应性鼻炎 症状评分 RQLQ评分 血清学指标 Xinqin Granules Azelastine Hydrochloride Nasal Spray allergic rhinitis symptom scores RQLQ scores serological index
  • 相关文献

参考文献6

二级参考文献44

  • 1刘光辉,祝戎飞.Serum IL-10 Level in Allergic Rhinitis Patients and Its Effect on Serum Total IgE[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(6):724-725. 被引量:2
  • 2韩德民,张罗,黄丹,武阳丰,董震,许庚,孔维佳,暴继敏,周兵,汪审清,王德辉,王秋萍.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. 被引量:409
  • 3Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update ( in collaboration with the World Health Organization, GAELEN and AllerGen). Allergy, 2008, 63(Suppl 86) :8-160.
  • 4Alvarez-Cuesta E, Bousquet J, Canoniea GW, et al. Standards for practical allergen-specific immunotherapy. Allergy, 2006, 61 ( Suppl 82) : 1-20.
  • 5Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy, 2007, 62 : 367-372.
  • 6Salib RJ, Howarth PH. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf, 2003, 26: 863-893.
  • 7Beger WE, White MV, Rhinitis Study Group. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol, 2003, 91: 205-211.
  • 8Pearlman DS, Grossman J, Meltzer EO. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 2003, 91: 258-262.
  • 9Lieberman PL, Settipane RA. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. Allergy Asthma Proc, 2003, 24: 95-105.
  • 10Sale M, Lyness W, Perhach J, et al. Lack of effect of coadministration of erythromycin with azelastine on pharmacokinetic or ECG parameters. Ann Allergy Asthma Immunol, 1996, 76: 91.

共引文献2557

同被引文献89

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部